Abeona Therapeutics Inc.(ABEO)
Biotechnology
Gene Therapy & Gene Editing
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-15 | Silverstein Christine Berni Director | Sale | -18,160 | -13.19%119,562 | $5.71 | $103,695 | View SEC filing | |
| 2026-06-09 | Vazzano Joseph Walter Chief Financial Officer | Sale | -49,338 | -8.69%518,437 | $5.38 | $265,242 | View SEC filing | |
| 2026-06-09 | Vasanthavada Madhav Chief Commercial Officer | Sale | -9,620 | -3.07%303,451 | $5.36 | $51,549 | View SEC filing | |
| 2026-06-09 | Seshadri Vishwas Chief Executive Officer | Sale | -56,344 | -3.94%1,374,079 | $5.36 | $301,921 | View SEC filing | |
| 2026-06-09 | O'Malley Brendan M. SVP, Chief Legal Officer | Sale | -11,131 | -2.47%440,003 | $5.36 | $59,646 | View SEC filing | |
| 2026-05-22 | Alvino Mark Director | Sale | -6,500 | -7.73%77,565 | $5.46 | $35,463 | View SEC filing | |
| 2026-05-11 | Vasanthavada Madhav Chief Commercial Officer | Sale | -5,548 | -1.74%313,071 | $5.96 | $33,073 | View SEC filing | |
| 2026-03-31 | Seshadri Vishwas Chief Executive Officer | Sale | -29,985 | -2.05%1,430,423 | $4.38 | $131,481 | View SEC filing | |
| 2026-03-16 | Vazzano Joseph Walter Chief Financial Officer | Sale | -785 | -0.14%567,775 | $4.76 | $3,737 | View SEC filing | |
| 2026-02-04 | Silverstein Christine Berni Director | Sale | -20,070 | -12.72%137,722 | $5.09 | $102,168 | View SEC filing | |
| 2026-02-02 | Wuchterl Donald A. Director | Sale | -14,814 | -8.11%167,935 | $5.09 | $75,412 | View SEC filing | |
| 2026-02-02 | Crombez Eric Director | Sale | -16,284 | -20.42%63,456 | $5.09 | $82,895 | View SEC filing | |
| 2026-02-02 | Alland Leila Director | Sale | -18,065 | -9.42%173,614 | $5.09 | $91,962 | View SEC filing | |
| 2026-02-02 | Alvino Mark Director | Sale | -2,000 | -2.32%84,065 | $5.09 | $10,181 | View SEC filing | |
| 2026-01-26 | Vasanthavada Madhav Chief Commercial Officer | Sale | -12,610 | -3.81%318,619 | $5.29 | $66,658 | View SEC filing | |
| 2026-01-22 | Vazzano Joseph Walter Chief Financial Officer | Sale | -18,666 | -3.18%568,560 | $5.33 | $99,507 | View SEC filing | |
| 2026-01-22 | Seshadri Vishwas Chief Executive Officer | Sale | -69,832 | -4.56%1,460,408 | $5.33 | $372,267 | View SEC filing | |
| 2026-01-22 | O'Malley Brendan M. SVP, Chief Legal Officer | Sale | -13,578 | -2.92%451,134 | $5.33 | $72,383 | View SEC filing | |
| 2026-01-21 | Alvino Mark Director | Sale | -13,500 | -21.69%48,752 | $5.23 | $70,574 | View SEC filing | |
| 2025-12-29 | Seshadri Vishwas Chief Executive Officer | Sale | -25,000 | -2.10%1,164,818 | $5.31 | $132,740 | View SEC filing | |
| 2025-11-14 | Alvino Mark Director | Sale | -15,000 | -19.42%62,252 | $4.74 | $71,168 | View SEC filing | |
| 2025-10-16 | Seshadri Vishwas Chief Executive Officer | Sale | -249 | -0.02%1,189,818 | $5.49 | $1,366 | View SEC filing | |
| 2025-10-01 | O'Malley Brendan M. SVP, Chief Legal Officer | Sale | -9,366 | -2.60%350,763 | $5.39 | $50,516 | View SEC filing | |
| 2025-10-01 | Seshadri Vishwas Chief Executive Officer | Sale | -44,274 | -3.59%1,190,067 | $5.31 | $234,884 | View SEC filing | |
| 2025-10-01 | Vazzano Joseph Walter Chief Financial Officer | Sale | -9,035 | -1.95%453,631 | $5.39 | $48,730 | View SEC filing |
1-25 of 132